Allianz Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-36,205
Closed -$1.23M 2278
2022
Q1
$1.23M Hold
36,205
﹤0.01% 1769
2021
Q4
$1.4M Buy
36,205
+26,369
+268% +$1.15M ﹤0.01% 1757
2021
Q3
$531K Sell
9,836
-96,077
-91% -$4.51M ﹤0.01% 2220
2021
Q2
$3.54M Buy
105,913
+21,345
+25% +$586K ﹤0.01% 1257
2021
Q1
$1.74M Buy
84,568
+10,068
+14% +$231K ﹤0.01% 1455
2020
Q4
$1.3M Buy
+74,500
New +$1.34M ﹤0.01% 1425
2018
Q2
Sell
-891
Closed -$31K 2627
2018
Q1
$31K Buy
+891
New +$34.5K ﹤0.01% 2610
2016
Q1
Sell
-20,560
Closed -$4.86M 2496
2015
Q4
$4.86M Buy
+20,560
New +$4.48M 0.01% 1361
2013
Q3
Sell
-9,107
Closed -$2.13M 1780
2013
Q2
$2.13M Buy
+9,107
New +$1.79M ﹤0.01% 1192

Other funds holding CLDX